Cargando…

"Concomitant immunity" in murine tumours of non-detectable immunogenicity.

Various immunization assays were used to demonstrate the lack of immunogenicity of three BALB/c tumours of spontaneous origin and of a fourth one resulting from foreign body tumorigenesis. All four tumours inhibited the growth of a second implant of the same tumour into the contralateral flank. In o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruggiero, R. A., Bustuoabad, O. D., Bonfil, R. D., Meiss, R. P., Pasqualini, C. D.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1985
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976815/
https://www.ncbi.nlm.nih.gov/pubmed/2981538
_version_ 1782135133109747712
author Ruggiero, R. A.
Bustuoabad, O. D.
Bonfil, R. D.
Meiss, R. P.
Pasqualini, C. D.
author_facet Ruggiero, R. A.
Bustuoabad, O. D.
Bonfil, R. D.
Meiss, R. P.
Pasqualini, C. D.
author_sort Ruggiero, R. A.
collection PubMed
description Various immunization assays were used to demonstrate the lack of immunogenicity of three BALB/c tumours of spontaneous origin and of a fourth one resulting from foreign body tumorigenesis. All four tumours inhibited the growth of a second implant of the same tumour into the contralateral flank. In our tumour models "concomitant immunity" (1) was not mediated by macrophage or T-cell dependent immune reactions: both thymectomized BALB/c and nude mice (treated or untreated with silica) gave the same results as intact mice; (2) showed some degree of non-specificity, inhibiting the growth of a different tumour in 3/4 cases; though, the existence of a specific component could not be discarded; (3) was proportional to the volume of the primary tumour at the time of the second challenge; (4) was dependent on actively growing primary tumour, not being obtained with progressively increasing daily inocula of irradiated tumour cells; (5) was detectable in an actively growing secondary tumour; recurrent growth after partial surgical excision was inhibited and (6) involved cytostasis of the secondary tumour: a syngeneic graft of the overlying skin led to tumour growth while histological studies revealed the presence of viable tumour cells. It is postulated that "concomitant immunity" or resistance can be generated without the active participation of the immune system and that tumour-related factors are, in certain cases, responsible for blocking the growth of secondary tumours. IMAGES:
format Text
id pubmed-1976815
institution National Center for Biotechnology Information
language English
publishDate 1985
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19768152009-09-10 "Concomitant immunity" in murine tumours of non-detectable immunogenicity. Ruggiero, R. A. Bustuoabad, O. D. Bonfil, R. D. Meiss, R. P. Pasqualini, C. D. Br J Cancer Research Article Various immunization assays were used to demonstrate the lack of immunogenicity of three BALB/c tumours of spontaneous origin and of a fourth one resulting from foreign body tumorigenesis. All four tumours inhibited the growth of a second implant of the same tumour into the contralateral flank. In our tumour models "concomitant immunity" (1) was not mediated by macrophage or T-cell dependent immune reactions: both thymectomized BALB/c and nude mice (treated or untreated with silica) gave the same results as intact mice; (2) showed some degree of non-specificity, inhibiting the growth of a different tumour in 3/4 cases; though, the existence of a specific component could not be discarded; (3) was proportional to the volume of the primary tumour at the time of the second challenge; (4) was dependent on actively growing primary tumour, not being obtained with progressively increasing daily inocula of irradiated tumour cells; (5) was detectable in an actively growing secondary tumour; recurrent growth after partial surgical excision was inhibited and (6) involved cytostasis of the secondary tumour: a syngeneic graft of the overlying skin led to tumour growth while histological studies revealed the presence of viable tumour cells. It is postulated that "concomitant immunity" or resistance can be generated without the active participation of the immune system and that tumour-related factors are, in certain cases, responsible for blocking the growth of secondary tumours. IMAGES: Nature Publishing Group 1985-01 /pmc/articles/PMC1976815/ /pubmed/2981538 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Ruggiero, R. A.
Bustuoabad, O. D.
Bonfil, R. D.
Meiss, R. P.
Pasqualini, C. D.
"Concomitant immunity" in murine tumours of non-detectable immunogenicity.
title "Concomitant immunity" in murine tumours of non-detectable immunogenicity.
title_full "Concomitant immunity" in murine tumours of non-detectable immunogenicity.
title_fullStr "Concomitant immunity" in murine tumours of non-detectable immunogenicity.
title_full_unstemmed "Concomitant immunity" in murine tumours of non-detectable immunogenicity.
title_short "Concomitant immunity" in murine tumours of non-detectable immunogenicity.
title_sort "concomitant immunity" in murine tumours of non-detectable immunogenicity.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976815/
https://www.ncbi.nlm.nih.gov/pubmed/2981538
work_keys_str_mv AT ruggierora concomitantimmunityinmurinetumoursofnondetectableimmunogenicity
AT bustuoabadod concomitantimmunityinmurinetumoursofnondetectableimmunogenicity
AT bonfilrd concomitantimmunityinmurinetumoursofnondetectableimmunogenicity
AT meissrp concomitantimmunityinmurinetumoursofnondetectableimmunogenicity
AT pasqualinicd concomitantimmunityinmurinetumoursofnondetectableimmunogenicity